TTRX

Turn Therapeutics Inc.

Healthcare · Biotechnology

13.00$ +4.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TTRX
Line item	2023	2024	2025
Revenue	0.00	0.00	0.00
Research & Development	0.00	0.02	0.02
Selling, General & Administrative	0.17	0.12	0.41
Total Operating Expenses	0.17	0.13	0.43
Operating Income	-0.17	-0.13	-0.43
Pre-Tax Income	-0.17	-0.13	-0.23
Net Income	-0.17	-0.13	-0.23
EBITDA	-0.17	-0.13	-0.23

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.